Main > A1. CORP. INDEX. Jn-Jz > Johns Hopkins University/P C2 > 2004. 10.25.2004. (Cambrex..)

---

Cambrex licenses contaminant detection technology from the Johns Hopkins University
October 25, 2004
From a press release
EAST RUTHERFORD, N.J. -- Cambrex Bio Science Walkersville, Inc., a subsidiary of Cambrex Corporation (NYSE: CBM), is pleased to announce that it has signed an exclusive license agreement with The Johns Hopkins University, Baltimore, MD, for access to two novel, quantitative assay technologies for the detection of contaminants such as pathogens in drugs, beverages and food. The technologies will be used to develop products and services for use in microbial testing of drugs, vaccines, biopharmaceuticals, cell therapeutics, nutraceuticals, cosmetics and food.
(Logo: http://www.newscom.com/cgi-bin/prnh/20000613/CAMBREXLOGO )
"This license from Johns Hopkins extends our capabilities to identify and quantify pathogens utilizing the recently licensed Epoch MGB Eclipse(TM) technology and the recently acquired Genolife know-how," commented Dave Eansor, President Cambrex Bioproducts. "We will leverage our success and experience with endotoxin and mycoplasma detection testing to establish a market-leading position in patient and consumer product safety testing for the drug, food and personal care markets."



2004. 10.25.2004. (Cambrex..)'s products
This section has no products